Cargando…

De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening

BACKGROUND: New cervical cancer screening guidelines recommend primary human papillomavirus (HPV) testing for women age 30–65 years. Healthcare organizations are preparing to de-implement the previous recommended strategies of Pap testing or co-testing (Pap plus HPV test) and substitute primary HPV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hahn, Erin E., Munoz-Plaza, Corrine, Altman, Danielle E., Hsu, Chunyi, Cannizzaro, Nancy T., Ngo-Metzger, Quyen, Wride, Patricia, Gould, Michael K., Mittman, Brian S., Hodeib, Melissa, Tewari, Krishnansu S., Ajamian, Lena H., Eskander, Ramez N., Tewari, Devansu, Chao, Chun R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461958/ https://www.ncbi.nlm.nih.gov/pubmed/34556189 http://dx.doi.org/10.1186/s43058-021-00211-z

Ejemplares similares

Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020
por: Miller, Maureen J., et al.
Publicado: (2021)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer
por: Eskander, Ramez N., et al.
Publicado: (2014)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome
por: Eskander, Ramez N., et al.
Publicado: (2015)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
por: Brueseke, Taylor J, et al.
Publicado: (2013)

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
por: Pearre, Diana C, et al.
Publicado: (2018)

Anti-angiogenesis therapy, synthetic lethality, and checkpoint inhibition in ovarian cancer: state of the science and novel combinations
por: Liu, Marisa C, et al.
Publicado: (2018)

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
por: Wolford, Juliet E., et al.
Publicado: (2017)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California
por: Chao, Chun R., et al.
Publicado: (2022)

Oncofertility in the setting of advanced cervical cancer - A case report
por: Gordon, Catherine, et al.
Publicado: (2018)

Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives
por: Yared, Nicholas, et al.
Publicado: (2021)

Lung cancer diagnosed on pap smear: A case report and review of the literature
por: Leaf, Marie-Claire, et al.
Publicado: (2021)

Cervical cancer in Tanzania: A systematic review of current challenges in six domains
por: Runge, Ava S., et al.
Publicado: (2019)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management
por: Grisham, Rachel, et al.
Publicado: (2018)

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review
por: Deignan, Caroline, et al.
Publicado: (2021)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)

Stakeholder Perspectives of Australia’s National HPV Vaccination Program
por: Swift, Caitlin, et al.
Publicado: (2022)

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
por: Guillaume, Dominique, et al.
Publicado: (2022)

A pharmacist’s guide to human papillomavirus (HPV)
por: Cable, Cheryl E., et al.
Publicado: (2022)

Recent Developments in Human Papillomavirus (HPV) Vaccinology
por: Williamson, Anna-Lise
Publicado: (2023)

Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
por: Kovanda, Anja, et al.
Publicado: (2011)

A stakeholder-driven agenda for advancing the science and practice of scale-up and spread in health
por: Norton, Wynne E, et al.
Publicado: (2012)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents
por: Lismidiati, Wiwin, et al.
Publicado: (2021)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

A Cross-Sectional Study for Prevalence and Association of Risk Factors of Chronic Kidney Disease Among People With Type 2 Diabetes in the Indian Setting
por: Tewari, Ajoy, et al.
Publicado: (2021)

Effect of COVID 19 Lockdown on glycemic parameters in people with type 2 diabetes
por: Tewari, Ajoy, et al.
Publicado: (2021)

ODP174 Correlation of Advanced Fibrosis and Coronary Artery Disease Risk Scores in People With Type 2 Diabetes in a Tertiary Care Centre
por: Tewari, Ajoy, et al.
Publicado: (2022)

hpvPDB: An Online Proteome Reserve for Human Papillomavirus
por: Kumar, Satish, et al.
Publicado: (2013)

Co-occurrence of human papillomavirus (HPV) in newborns and their parents
por: Skoczyński, Mariusz, et al.
Publicado: (2019)

An unusual presentation of an oral human papillomavirus (HPV) lesion
por: Casu, Cinzia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6fpga7g61rh06su58r53h7qae3